P35269 (T2FA_HUMAN) Homo sapiens (Human)

General transcription factor IIF subunit 1 UniProtKBInterProSTRINGInteractive Modelling

517 aa; Sequence (Fasta)

Available Structures

30 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Human core-PIC in the open state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;5-180
Assess
Human holo-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P24928; P29083; P29084; P30876; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 10×ZN;5-180
Assess
Human core-PIC in the initial transcribing state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;5-180
Assess
Human core-PIC in the closed state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;5-180
Assess
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P32780; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 17×ZN;SF4;5-180
Assess
Human core-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P19387; P19388; P20226; P24928; P29083; P29084; P30876; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;5-180
Assess
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 11×ZN;5-180
Assess
Human holo-PIC in the open state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 11×ZN;5-180
Assess
Human holo-PIC in the initial transcribing state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 11×ZN;5-180
Assess
RNA polymerase II pre-initiation complex with open promoter DNA Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
SF4; 15×ZN;ADP;MG;BEF;5-180
Assess
RNA polymerase II core pre-initiation complex with open promoter DNA Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P20226; P29083; P29084; P52655; P52657; P60899; Q00403;
10×ZN;MG;5-180
Assess
RNA polymerase II pre-initiation complex with closed promoter DNA in proximal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
SF4; 17×ZN;MG;5-180
Assess
RNA polymerase II pre-initiation complex with closed promoter DNA in distal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
SF4; 17×ZN;MG;5-180
Assess
RNA polymerase II core pre-initiation complex with closed promoter DNA in proximal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P20226; P29083; P29084; P52655; P52657; P60899; Q00403;
10×ZN;MG;5-180
Assess
Human Mediator with RNA Polymerase II Pre-initiation complex Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; A0JLT2; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; O43513; O60244; O75586; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q92759; Q96G25; Q96HR3; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9P086; Q9Y3C7;
SF4; 18×ZN;MG;5-180
Assess
RNA polymerase II core pre-initiation complex with closed promoter DNA in distal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P20226; P29083; P29084; P52655; P52657; P60899; Q00403;
10×ZN;MG;5-180
Assess
TFIID-based intermediate PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P20226; P21675; P29083; P29084; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
10×ZN;MG;5-176
Assess
p53-bound TFIID-based core PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P20226; P21675; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;5-176
Assess
TFIID-based core PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P20226; P21675; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;5-176
Assess
Structure of the human Mediator-bound transcription pre-initiation complex Heteromer
A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P19447; P20226; P24928; P29083; P29084; P30876; P32780; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7;
MG; 16×ZN;SF4;19-183
Assess
CRYSTAL STRUCTURE OF THE RAP30/74 INTERACTION DOMAINS OF HUMAN TFIIF Heteromer
P13984;
5-153
Assess
TFIID-based holo PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
16×ZN;SF4;MG;5-150
Assess
TFIID-based intermediate PIC on PUMA promoter Heteromer
A0A480TA59; A0A481BYI6; A0A481DF93; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; O00268; P13984; P20226; P21675; P29083; P29084; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
10×ZN;MG;5-150
Assess
TFIID-based core PIC on PUMA promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P20226; P21675; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;5-150
Assess
p53-bound TFIID-based holo PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
16×ZN;SF4;MG;5-150
Assess
Crystal structure of RAP74 C-terminal domain complexed with FCP1 C-terminal peptide Heteromer
Q9Y5B0;
SO4;ZN;451-517
Assess
NMR structure of a complex formed by the C-terminal domain of human RAP74 and a phosphorylated pept… Heteromer
Q9Y5B0;
451-517
Assess
NMR Structure of a Complex Containing the TFIIF Subunit RAP74 and the RNAP II CTD Phosphatase FCP1 Heteromer
Q9Y5B0;
451-517
Assess
CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE RAP74 SUBUNIT OF HUMAN TRANSCRIPTION FACTOR IIF (…monomerZN;449-517
Assess
Solution Structure of the Carboxyl-Terminal Domain of RAP74 and NMR Characterization of the FCP-Bin…monomer451-517
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer0.526o9l.1.S5-180
100.00
Assess

Alignments